Q20255 AF NFT

Tetratricopeptide repeat protein 21 homolog

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeic3njvuku2isphjoz3syw5apqcw43x5oi56gacyl6xmkgcrzws7ca/metadata.json
IPFS of structure file: 
bafybeidxhinztr4qg6oremwowsvp7tt7q5ykqw7zi4felbzoagcdhji2ky/AF-Q20255-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xe41239a9Da8F7CdC26b36b3F46f4954c048a8D15
First NFT owner address (bech32): 
genesis1usfrn2w63a7dcf4ndvl5day4fszg4rg46y3g0y
Current NFT ID #481358 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
481358
Accession (UniProt):
Q20255
Name::
Tetratricopeptide repeat protein 21 homolog
Experimental Method:
Predicted structure
Sequence source:
CAENORHABDITIS ELEGANS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q20255 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q20255|TTC21_CAEEL Tetratricopeptide repeat protein 21 homolog OS=Caenorhabditis elegans OX=6239 GN=ift-139 PE=1 SV=3 MDSESDDNPNDPEDRKKWGHKDVEHWRAVSNVHYYAREGYFGTAILVCDGRLATIKDPALAILKGVCLTLLGKIPDAIRHLETFVTDNDVALGALHALKWAHASAFNPDNKSIVEIETEISTRARNEKTPYTSYATASEVLYFAGEYQKSKQMLDIARKRATEKHAKHYCLLGWIELALGKKQKSTQELFEKAGGQEYPDGNIGRCKILEGHHSAPEMKVAANELAISTIHFLPGHIEKAKASIMMKDWRGVMDCIMNADQPEGSNPYIEVLRTVHGICYAGEVSMLKRTLQLLLKSLDENEATNHVLYARITKLLVSISGRDEKILRHARDFLTRALKISRKPDYVALSMRIAFGLGGAKEVSTLSQELVALDCEDSYAVLSSVVSMLMISRVSDARAQFDILPSAHPKLLESPLYYLIASVLAKQSKDKSFENFRQHIENLVEMLRNQLQSFPFGLDYLSLFSSDLLYSAVEQCFDFYPLVPIKAPDDCMKLTAKTLQMIYDVAPGLAHCTLQLARNSYLCSNTNAAEKWIEKVLDKDDSLADAHILRAELILDRGGKITDADDALVTGLNFNFKLRETSLYHLIKSKTFKKRNENDEAIKTLKMALQIPRKEPSKNLFQPKESADTHKISVQLELIDTLQHMKRIQEAETTMTDALAEWAGQPEQDQLVIAQAQLYLTKGHVERALGILKKIQPGQSNFHLSRIKMAEIYLEEKKDKRMFAACYRELLKVEATPGSYSLLGDAFMKVQEPEDAINFYEQALKMQSKDVQLAEKIGEAYVMAHLYSKAVNFYESSMNIYKDKNMRLKLANLLLKLRNFEKCEKVLRAPFERDPEPVGTETIQTYIQFLLLLAECHEMMDNVPEAMNDFEKAKSLHSRIQDKTLTAALKKEGARICNLQAELLYRRREFSQAVDICKQALAYHETDLKANLLLSKIFKEENKWTLVLQPCQTVIQVDPHNDEANSILADFYYIRSEAAHASTSYTTLLNTNPQHWHALSRVVELFCRNGEQNAAEKHLDRAKEVNPRCVTESGYNVCRGRFEWYTGDQNEALRYYSRTKDSAAGWREKALYYMIDICLNPDNEIIIDENSVENPETTIVEEASEQQKLAKYYLDLLGKLPTTDRFLLAQNFIRMHTTDKSAIQAALDEFNRMAFNADRSQVTNVGAVFGVARGHVLLKQVQKAKTVLKMVNGRVWNFDDSDYLEKCWLMLADIYINQNKNDQAVTFLDLVFKYNCNCLKAFELYGYMREKEQKYVEAYKMYEKAFMATKERNPGFGYKLAFTYLKAKRLFACIETCQKVLDLNPQYPKIKKEIMDKAKALIRT